Kspine, Inc. is developing implantable devices to treat spinal deformity, a potential worldwide market exceeding $1B. Our initial market is scoliosis, a dysfunctional twisting and curvature of the spine. The Kspine system allows surgeons to reduce the morbidity of deformity surgery with a procedure that is quicker, safer, and more cost-effective than existing techniques. We obtained the CE Mark, and are currently recruiting patients for a clinical trial outside the U.S. Our investors include Split Rock Partners and Abingworth.